Nivolumab/pembrolizumab
- 期刊名称Reactions Weekly
- 卷第1608卷
- 期第1期
- 印刷ISSN0114-9954
- 电子ISSN1179-2051
- 文件大小165.06KB
- 发表时间2016-7
- DOI10.1007/s40278-016-19216-6
- 页码204-204
Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomilvon Bergmann, Klaus; Laeis, Petra; Püchler, Kurt; Sudhop, Thomas; Schwocho, Lee R; Gonzalez, Lisette · Journal of Hypertension · 2001
Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe HypertensionProf Roberto Fogari, Stefano Taddei, Merete Holm-Bentzen, Jacek Baszak, Lorenzo Melani, Kai Schumacher · 2010
Population Pharmacokinetics of Olmesartan Following Oral Administration of its Prodrug, Olmesartan MedoxomilDr Kazutaka Yoshihara, Yuying Gao, Hiroshi Shiga, D. Russell Wada, Masafumi Hisaoka · 2005
Olmesartan MedoxomilGregory T. Warner, Blair Jarvis · 2002
Olmesartan MedoxomilKlaus O. Stumpe · 2002
Olmesartan MedoxomilDanilo Fliser · 2002
Olmesartan MedoxomilToshio Ogihara · 2002
Olmesartan MedoxomilGordon T. McInnes · 2002
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991